Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > Surprise

<< Previous

Bullboard Posts

Next >>

Comment by stockbuphoonon Jul 24, 2022 9:32am

208 Views

Post# 34846161

RE:Surprise

there is nothing left... preclinical molecules have no interest for thomvest. This will wind up. It will be interesting to see who owns IP for 4050 and it's derivatives. Was it all a complete fraud from day one?

inventors wrote: That would be negative news, but best to know safery tolerance....?

There still seems to be scetchy info on Ryplazmin...lmnl own 30%...?

Mfg plant....?

The Antagonists switches...pre-clinical new indications...?

GPR84....?

OXER1...?

Clean shelf of a listed company. 15M cap and credit...perhaps today will be the new Bottom...?

Pierre performed better...?